(Q33848065)

29 July 2017

1 reference

title

Pneumococcal vaccination for older adults: the first 20 years (English)

1 reference

29 July 2017

1

Fedson DS

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

15 Suppl 1

1 reference

29 July 2017

page(s)

21-30

1 reference

Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.

29 July 2017

cites work

1 reference

12 December 2020

Novel pneumococcal surface proteins: role in virulence and vaccine potential

1 reference

12 December 2020

Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

1 reference

12 December 2020

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

12 December 2020

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

1 reference

12 December 2020

Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions

1 reference

12 December 2020

Influenza vaccination in 22 developed countries: an update to 1995

1 reference

12 December 2020

Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease

1 reference

12 December 2020

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

12 December 2020

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

12 December 2020

Effectiveness of pneumococcal vaccine

1 reference

12 December 2020

Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine

1 reference

12 December 2020

Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly.

1 reference

12 December 2020

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

12 December 2020

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

12 December 2020

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

12 December 2020

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

1 reference

12 December 2020

Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

1 reference

12 December 2020

Prospects for the use of new vaccines in developing countries: cost is not the only impediment.

1 reference

12 December 2020

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

12 December 2020

The clinical effectiveness of pneumococcal vaccination: a brief review

1 reference

12 December 2020

Prevention of pneumococcal pneumonia by vaccination

1 reference

12 December 2020

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

1 reference

12 December 2020

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

1 reference

12 December 2020

Immunization of elderly people with polyvalent pneumococcal vaccine

1 reference

12 December 2020

Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies

1 reference

12 December 2020

Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997

1 reference

12 December 2020

Potential interventions for the prevention of childhood pneumonia in developing countries: a systematic review.

1 reference

12 December 2020

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

12 December 2020

Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials?

1 reference

12 December 2020

The pneumococcal vaccine after 15 years of use.

1 reference

12 December 2020

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

1 reference

12 December 2020

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

1 reference

12 December 2020

Invasive pneumococcal infection in South and West England.

1 reference

12 December 2020

10.2165/00002512-199915001-00003

Identifiers

DOI

0 references

Dimensions Publication ID

1040304053

0 references

1 reference